Fig. 2From: Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trialKaplan‒Meier curve of progression-free survival (PFS). NR not reached, CI confidence intervalBack to article page